BofA analyst Craig Siegenthaler lowered the firm’s price target on Invesco (IVZ) to $15 from $18 and keeps a Neutral rating on the shares. In Q1, Invesco reported 5% organic growth, which the firm expects to decline to 1% in Q2 as it anticipates de-risking activity to dampen flows, especially in equities, the analyst tells investors in a post-earnings note. The firm has lowered its 2025, 2026 and 2027 EPS forecasts, driven by a more challenging macro backdrop, including lower equity markets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVZ:
- Invesco’s Hold Rating: Balancing Organic Growth and Near-Term Challenges Amid Macroeconomic Pressures
- Invesco price target raised to $14 from $13 at Barclays
- Invesco Ltd. Reports Strong Q1 2025 Results
- Invesco Ltd. Earnings Call Highlights Growth and Challenges
- Invesco Unveils Strategic Initiative to Boost Efficiency